Your browser doesn't support javascript.
Development of pemphigus vulgaris after the second dose of the mRNA-1273 SARS-Cov-2 vaccine.
Koutlas, Ioannis G; Camara, Renee; Argyris, Prokopios P; Davis, Mark Denis P; Miller, Daniel D.
  • Koutlas IG; Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Minnesota, Minneapolis, Minnesota, USA.
  • Camara R; In Private Practice, Wayzata, Minnesota, USA.
  • Argyris PP; Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Minnesota, Minneapolis, Minnesota, USA.
  • Davis MDP; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA.
  • Miller DD; Howard Hughes Medical Institute, University of Minnesota, Minneapolis, Minnesota, USA.
Oral Dis ; 28 Suppl 2: 2612-2613, 2022 11.
Article in English | MEDLINE | ID: covidwho-1555638
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pemphigus / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Oral Dis Journal subject: Dentistry Year: 2022 Document Type: Article Affiliation country: Odi.14089

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pemphigus / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Oral Dis Journal subject: Dentistry Year: 2022 Document Type: Article Affiliation country: Odi.14089